(firstQuint)Safety and Tolerability of Nexvax2 in Subjects With Celiac Disease.

 This is a randomized, double-blind, placebo-controlled, study to evaluate the safety and tolerability of Nexvax2 preceded by dose titration period in patients with celiac disease currently on a gluten-free diet.

 The study will consist of a Screening Period, a Treatment Period, and a Follow-up Period.

 Eligible subjects will be enrolled in one of three cohorts according to whether they are homozygous or not homozygous for both genes coding for HLA-DQ2.

5.

.

 Safety and Tolerability of Nexvax2 in Subjects With Celiac Disease@highlight

A randomized, double-blind, placebo-controlled, dose titration trial, stratified by Human Leukocyte Antigen (HLA)-DQ2.

5 genotype in subjects with celiac disease.

